<?xml version="1.0" encoding="UTF-8"?>
<ref id="B54-viruses-09-00234">
 <label>54.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Haan</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Verweij</surname>
    <given-names>W.R.</given-names>
   </name>
   <name>
    <surname>Holtrop</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Brands</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>van Scharrenburg</surname>
    <given-names>G.J.</given-names>
   </name>
   <name>
    <surname>Palache</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Agsteribbe</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Wilschut</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity</article-title>
  <source>Vaccine</source>
  <year>2001</year>
  <volume>19</volume>
  <fpage>2898</fpage>
  <lpage>2907</lpage>
  <pub-id pub-id-type="doi">10.1016/S0264-410X(00)00556-9</pub-id>
  <pub-id pub-id-type="pmid">11282201</pub-id>
 </element-citation>
</ref>
